Summary
Duchenne muscular dystrophy (DMD) is the most common sex linked lethal disease in man (one case in about 4000 male live births). The patients are wheelchair bound around the age of 8–10 years and usually die before the age of 20 years. The mutation rate, estimated by different methods and from different population studies, is in the order of 7×10-5, which is higher than for any other X-linked genetic disease. Moreover, unlike other X linked diseases such as hemophilia A or Lesh-Nyhan's disease, there seems to be no sex difference for the mutation rates in DMD. Several observations of DMD in girls bearing X-autosomal translocations and linkage studies on two X chromosomal DNA restriction fragment length polymorphisms indicate that the DMD locus is situated on the short arm of the X chromosome, between Xp11 and Xp22. It may be of considerable length, and perthaps consisting of actively coding and non-active intervening DNA sequences. Thus unequal crossing over during meiosis in females could theoretically account for a considerable proportion of new mutations.
However, there is no structurally or functionally abnormal protein known that might represent the primary gene product, nor has any pathogenetic mechanism leading to the observed biochemical and histological alterations been elucidated. Among the numerous pathogenetic concepts the hypothesis of a structural or/and functional defect of the muscular plasma membrane is still the most attractive. It would explain both the excess of muscular constituents found in serum of patients and carriers, such as creatine kinase (CK), as well as the excessive calcium uptake by dystrophic muscle fibres, which, prior to necrosis, could lead to hypercontraction, rupture of myofilaments in adjacent sarcomeres and by excessive Ca uptake to mitochondrial damage causing crucial energy loss.
The results of studies on structural and functional memthrane abnormalities in cells other than muscle tissue, e.g., erythrocytes, lymphocytes and cultured fibroblasts, indicate that the DMD mutation is probably demonstrable in these tissues. However, most of the findings are still difficult to reproduce or even controversial.
DMD is an incurable disease; therefore most effort, in research as well as in practical medicine, is concentrated upon its prevention. Unfortunately the disease cannot yet be diagnosed prenatally. Potential DMD carriers among female relatives of the patients may be identified by pathological heterozygote tests, of which determination of serum CK activity is probably still the most reliable method, allowing the detection of about 70% of adult and probably up to 90% of carriers at school age. Because of the high mutation rate, assessment of individual heterozygote risks in female relatives of isolated DMD cases is of special importance. For the calculations a maximum of genealogical and phenotype information on unaffected male and on heterozygote tests in female relatives is needed to obtain credible risk figures. However, estimating a consultand's risk and passing on this information is only one aspect of genetic counselling in DMD. At least as important is information on the medical, psychological and social impacts of the disease (burden) and the possibility of maintaining a long-term contact between the couples at risk and the team involved in medical, genetic and social problems of the disease. Neonatal CK screening for DMD, although without any therapeutical consequence, could theoretically lead to the prevention of “secondary” cases, accounting for some 15% of all DMD patients born, but an almost equal prevention rate of such cases would be achieved if CK examinations were limited to all boys with delayed motor development during the first 2 years of life. Finally, it is believed that the two most important preventive problems in DMD, carrier detection and prenatal diagnosis, will ultimately be solved by means of the rapidly advancing DNA technology.
Similar content being viewed by others
References
Accardo PJ (1981) An early case report of muscular dystrophy. A footnote to the history of neuromuscular disorders. Arch Neurol 38:144–146
Adornato BT, Corash L, Engel WK (1977) Erythrocyte survival in Duchenne muscular dystrophy. Neurology 27:1093–1094
Aebi U, Richterich R, Stillhart H, Colombo JP, Rossi E (1961) Progressive Muskeldystrophie. III. Serumenzyme bei der Muskeldystrophie im Kindesalter. Helv Paediatr Acta 16:543–564
Afifi AK, Bergman RA, Zellweger H (1973) A possible role for electron microscopy in detection of carriers of Duchenne type muscular dystrophy. J Neurol Neurosurg Psychiatry 36:643–650
Ahmad M, Sanderson JE, Dubowitz V, Hallidie-Smith KA (1978) Echocardiographic assessment of left ventricular function in Duchenne's muscular dystrophy. Br Heart J 40:734–740
Alberts MC, Samaha FJ (1974) Serum pyruvate kinase in muscle disease and carrier states. Neurology 24:462–464
Allen JE, Rodgin DW (1960) Mental retardation in association with progressive muscular dystrophy. Am J Dis Child 100:208–211
Ando T, Shimizu T, Kato T, Ohsawa M, Fukuyama Y (1978) Myoglobinemia in children with progressive muscular dystrophy. Clin Chim Acta 85:17–22
Araki S, Mawatari S (1971) Ouabain and erythrocyte ghost adenosine triphosphatase. Effects in human muscular dystrophies. Arch Neurol 24:187–190
Austin L, Katz S, Jeffrey PL, Shield L, Arthur H, Mazzoni M (1983) Thermodynamic behaviour of membrane enzymes in Duchenne muscular dystrophy. J Neurol Sci 58:143–151
Ballantyne JP, Hansen S (1974) New method for the estimation of the number of motor units in a muscle: II. Duchenne, limbgirdle and facioscapulohumeral and myotonic muscular dystrophies. J Neurol Neurosurg Psychiatry 37:1195–1201
Becker PE (1953) Dystrophia musculorum progressiva. Thieme, Stuttgart
Becker PE (1964) Myopathien. In: Becker PE (ed) Humangenetik. Ein kurzes Handbuch in 5 Bänden, Bd III/1. Thieme, Stuttgart, pp 420–427
Becker PE (1972) Neues zur Genetik und Klassifikation der Muskeldystrophien. Humangenetik 17:1–22
Becker PE, Kiener F (1955) Eine neue X-chromosomale Muskeldystrophie. Arch Psychiatr Z Neurol 193:427–448
Becker PE, Lenz F (1955, 1956) Zur Schätzung der Mutationsrate der Muskeldystrophien. Z menschl Vererb Konstitutionsl 33: 42–56
Beckmann R, Scheuerbrandt G (1979) Screening auf erhöhte Kreatinkinase-Aktivitäten zur Früherkennung der Duchenne-Muskeldystrophie. Fortschr Med 97:1733–1736
Berg G, Conte F (1974) Duchenne dystrophy in a female with a structurally abnormal X-chromosome. Neurology 24:356
Bertorini TE, Bhattacharya SK, Palmieri GMA, Chesney CM, Pifer D, Baker B (1982) Muscle calcium and magnesium content in Duchenne muscular dystrophy. Neurology 32:1088–1092
Beyer P, Stephan M, Oberling F, Daya Y (1977) Deformation des erythrocytes chez les sujets atteints de myopathie de Duchenne de Bologne. Presse Méd 6:1663–1664
Biggs R, Rizza CR (1976) The sporadic case of hemophilia A. Lancet ii:431–433
Bitter K (1964) Erhebungen zur Bestimmung der Mutationsrate für Haemophilie A und B in Hamburg. Z Menschl Vererb Konstitutionsl 37:251–268
Blith H, Pugh RJ (1959) Muscular dystrophy in childhood. The genetic aspect. Ann Hum Genet 23:127–163
Bodensteiner JB, Engel AG (1978) Intracellular calcium accumulation in Duchenne dystrophy and other myopathies: A study of 567 000 muscle fibres in 114 biopsies. Neurology 28:439–446
Boulé M, Vanasse M, Brakier-Gingras L (1979) Decrease in the rate of protein synthesis from cultured fibroblasts of patients and carriers with Duchenne muscular dystrophy. J Canad Sci Neurol 6:355–358
Boxler K, Jerusalem F (1978) Hyperreactive (hyaline, opaque, dark) muscle fibres in Duchenne dystrophy. A biopsy study of 16 dystrophy and 205 other neuromuscular disease cases and controls. J Neurol 219:63–72
Bradley WG, Fullthorpe JJ (1978) Studies of sarcolemmal integrity in myopathic muscle. Neurology 28:670–676
Bradley WG, Kelemen J (1979) Editorial: Genetic counseling in Duchenne muscular dystrophy. Muscle and Nerve 2:325–327
Brambati B, Cornelio F, Dworzak F, Dones I (1980) Calciumpositive muscle fibres in fetuses at risk for Duchenne muscular dystrophy. Lancet ii:969–970
Brooks AP, Emery AEH (1977) The incidence of Duchenne muscular dystrophy in the south east of Scotland. Clin Genet 11:290–294
Brown HD, Chattpadhyay SK, Patel AB (1967) Erythrocyte abnormality in human myopathy. Science 157:1577–1578
Brown WF (1974) Sources of error in the methods for estimating motor unit numbers in the EDB and thenar muscles. III International Congress on Muscle Disease. Internat Congr Ser 334, Excerpta Medica, Abstr 190, pp 108–115
Bucher K, Ionasescu V, Hanson J (1980) Frequency of new mutants among boys with Duchenne muscular dystrophy. Am J Med Genet 7:27–46
Bundey S (1981) A genetic study of Duchenne muscular dystrophy in the West Midlands. J Med Genet 18:1–7
Bundey S, Crawley JM, Edwards JH, Westhead RA (1979a) Serum creatine kinase levels in pubertal, mature, pregnant, and postmenopausal women. J Med Genet 16:117–121
Bundey S, Edwards JH, Insley J (1979b) Carrier detection in Duchenne muscular dystrophy. Lancet i:881
Burghes AHM, Dunn MJ, Statham HE, Dubowitz V (1981) Analysis of cultured skin fibroblasts from patients with Duchenne muscular dystrophy using electrophoretic techniques. In: Allen RC, Arnaud P (eds) Electrophoresis '81. Walter de Gruyter, Berlin, pp 285–308
Burghes AHM, Dunn MJ, Statham HE, Dubowitz V (1982a) Analysis of fibroblast proteins in Duchenne muscular dystrophy: 1. Sodium dodecyl sulphate polyacrylamide gel electrophoresis. Electrophoresis 3:177–185
Burghes AHM, Dunn MJ, Statham HE, Dubowitz V (1982b) Analysis of skin fibroblast proteins in Duchenne muscular dystrophy: 2. Isoelectric focusing under dissociating conditions. Electrophoresis 3:185–196
Butterfield DA, Markesbery WR (1980) Specifity of biophysical and biochemical alterations in erythrocyte membranes in neurological disorders. Huntington's disease, Friedreich's ataxia, Alzheimer's disease, amyotrophic lateral sclerosis, and myotonic and Duchenne muscular dystrophy. J Neurol Sci 47:261–271
Butterfield DA, Chesnut DB, Appel SH, Roses AD (1976) Spin label study of erythrocyte membrane fluidity in myotonic and Duchenne dystrophies and myotonia congenita. Nature 263:159–161
Canal N, Frattola L, Smirne S (1975) The metabolism of cyclic 3′-5′-adenosine monophosphatase (cAMP) in diseased muscle. J Neurol 208:259–265
Canki N, Dutrillaux B, Tivadar I (1979) Dystrophie musculaire de Duchenne chez une petite fille proteuse d'une translocation t(X;3) (p21;q13) de novo. Ann Génet 22:35–39
Carpenter S, Karpati G (1979) Duchenne muscular dystrophy. Plasma membrane loss initiates muscle cell necrosis unless it is repaired. Brain 102:147–161
Carter ND, Heath R, Jeffrey S, Rodeck C (1982) Fetal plasma carbonic anhydrase III in Duchenne dystrophy. Lancet i:39–40
Caskey CT, Nussbaum RL, Cohan LC, Pollack L (1980) Sporadic occurrence of Duchenne muscular dystrophy: evidence for new mutation. Clin Genet 18:329–341
Cerri CG, Willner JH, Mirande AF (1982) Adenylate cyclase in Duchenne fibroblasts. J Neurol Sci 53:181–185
Cheeseman EA, Kilpatrick SJ, Stevenson AC, Smith CAB (1958) The sex ratio of mutation rates of sex-linked recessive genes in man with particular reference to Duchenne type muscular dystrophy. Ann Hum Genet 22:235–243
Chung CS, Morton NE (1959) Discrimination of genetic entities in muscular dystrophy. Am J Hum Genet 11:339–359
Cöers C, Telerman-Topet N, Gerard JH (1973) Terminal innervation ratio in neuromuscular disease: II. Disorders of lower motor neuron, peripheral nerve, and muscle. Arch Neurol 29:215–222
Coneally PM, Heuch I (1974) A computer program to determine genetic risks: a simplified version of PEDIG (Heuch and Li, 1972). Am J Hum Genet 26:773–775
Conlon T, Lingard PS, Tomkins JK (1983) Deformability and cell membrane properties of erthrocytes in Duchenne muscular dystrophy. Clin Chim Acta 130:139–147
Cowan J, MacDessi J, Stark A, Morgan G (1980) Incidence of Duchenne muscular dystrophy in New South Wales and the Australian capital territory. J Med Genet 17:245–249
Crisp DE, Ziter FA, Bray PF (1982) Diagnostic delay in Duchenne's muscular dystrophy. JAMA 247:478–480
Cullen MJ, Fulthorpe JJ (1975) Stages in fibre breakdown in Duchenne muscular dystrophy. J Neurol Sci 24:179–200
Cullen MJ, Parsons R (1977) Inclusion bodies in muscular dystrophy. Lancet ii:929
Cullen MJ, Mastaglia FL (1980) Morphological changes in dystrophic muscle. Br Med Bull 36:145–152
Danieli GA, Mostacciulo ML, Bonfante A, Angelini C (1977) Duchenne muscular dystrophy. A population study. Hum Genet 35:225–231
Danieli GA, Mostacciulo ML, Pilotto G (1978) Duchenne mutation rate. IRCS Medical Science 6:440
Danieli GA, Mostacciulo ML, Pilotto G, Angelini C, Bonfonge A (1980) Duchenne muscular dystrophy. Data from family studies. Hum Genet 54:63–68
Danilowicz D, Rutkowski M, Myung D, Schively D (1980) Echocardiography in Duchenne muscular dystrophy. Muscle and Nerve 3:298–303
Davie AM, Emery AEH (1978) Estimation of proportion of new mutants among cases of Duchenne muscular dystrophy. J Med Genet 15:339–345
Davies KE, Young BD, Elles RG, Hill ME, Williamson R (1981) Cloning of a representative genomic library of the human X chromosome after sorting by flow cytometry. Nature 293: 374–376
Davies KE, Pearson PL, Harper PS, Murray JM, O'Brien T, Sarfarazi M, Williamson R (1983) Linkage analysis of two cloned DNA sequences flanking the Duchenne muscular dystrophy locus on the short arm of the human X chromosome. Nucleic Acids Res 11:2303–2312
Dellamonica C, Collombel C, Cotte J, Addis P (1983) Screening for neonatal Duchenne muscular dystrophy by bioluminiscence measurement of creatine kinase in a blood sample spotted on paper. Clin Chem 29:161–163
Dennis NR, Evans K, Clayton B, Carter CO (1976) Use of creatine kinase for detecting severe X-linked muscular dystrophy carriers. Br Med J 2:577–579
Dhalla NS, McNamara DB, Balasubramian V, Greenlaw R, Tucker FR (1973) Alterations of adenosine triphosphatase activities in dystrophic muscle sarcolemma. Res Commun Chem Pathol Pharmacol 6:643–650
Drachman DB, Toyka KV, Myer E (1974) Prednisone in Duchenne muscular dystrophy. Lancet ii:1409–1412
Dreyfus JC, Schapira G (1962) Biochemistry of hereditary myopathies. Springfield, Charles C Thomas
Dreyfus JC, Schapira G, Schapira F (1954) Biochemical study of muscle in progressive muscular dystrophy. J Clin Invest 33: 794–797
Drummond LM (1979) Creatine phosphokinase levels in the newborn and their use in screening for Duchenne muscular dystrophy. Arch Dis Child 54:362–366
Dubowitz V (1960) Progressive muscular dystrophy of the Duchenne type in females and its mode of inheritance. Brain 83:432–439
Dubowitz V (1963) Myopathic changes in muscular dystrophy carriers. Proc R Soc Med 56:810–812
Dubowitz V (1965) Intellectual impairment in muscular dystrophy. Arch Dis Child 40:296–301
Dubowitz V (1978) Muscle disorders in childhood. In: Schaffer AJ, Markowitz M (eds) Major problems in clinical pediatrics, vol XVI. Saunders, London Philadelphia Toronto
Dubowitz V (1982) The female carrier of Duchenne muscular dystrophy. Br Med J 284:1423–1424
Dubowitz V, Crome L (1969) The central nervous system in Duchenne muscular dystrophy. Brain 92:805–808
Dubowitz V, Van Iddeninge D, Rodeck CH, Campbell S, Singer JD, Scheuerbrandt G, Moss DW (1978) Prenatal diagnosis in Duchenne muscular dystrophy: salvage of a normal male fetus. Lancet i:90
Duchenne de Boulogne GBA (1861) De l'éctrisation localisée et de son application à la pathologie et la thérapeutique. J. B. Baillière & Pils, Paris
Duchenne de Boulogne GBA (1868) Recherches sur la paralysie musculaire pseudohypertrophique, ou paralysie myosclérosique. Arch Gén Méd 11:5–25; 179–209; 305–321; 421–443; 552–588
Duncan CJ (1978) Role of intracellular calcium in promoting muscle damage: a strategy for controlling the dystrophic condition. Experienta 34:1531–1535
Ebashi S, Sugita H (1979) The role of calcium in physiological and pathological processes of skeletal muscle. In: Aguayo AJ, Karpati G (eds) Current topics in nerve and muscle research Amsterdam: Excerpta Medica, ICS No 445, pp 73–84
Ebashi S, Toyokura Y, Momoi H, Sugita H (1959) High creatine phosphokinase activity of sera of progressive muscular dystrophy patients. J Biochem (Tokyo) 46:103–104
Emery AEH (1964) Lyonisation of the X-chromosome. Lancet i:884
Emery AEH (1965) Muscle histology in carriers of Duchenne muscular dystrophy. I Med Genet 2:1–7
Emery AEH (1966a) Genetic linkage between the loci for colour blindness and Duchenne type muscular dystrophy. J Med Genet 3:92–95
Emery AEH (1966b) The use of serum creatine kinase for detecting carriers of Duchenne muscular dystrophy. In: Exploratory concepts in muscular dystrophy and related disorders. International Congress Series No 147 Excerpta Medica, Amsterdam, pp 90–97
Emery AEH (1969a) Abnormalities of the electrocardiogram in female carriers of Duchenne muscular dystrophy. Br Med J 2: 418–420
Emery AEH (1969b) Genetic counselling in X-linked muscular dystrophy. J Neurol Sci 8:579–587
Emery AEH (1977a) Muscle histology and creatine kinase levels in the foetus in Duchenne muscular dystrophy. Nature 266: 472–473
Emery AEH (1977b) Genetic considerations in the X-linked muscular dystrophies. In: Rowland LP (ed) Pathogenesis of human muscular dystrophies. Excerpta Medica Amstedam, pp 42–58
Emery AEH (1980) Duchenne muscular dystrophy. Genetic aspects, carrier detection and antenatal diagnosis. Br Med Bull 36:117–122
Emery AEH (1981) Genetic aspects of neuromuscular disease. In: Walton J (ed) Disorders of voluntary muscle, 4th ed. Churchill Livingstone, Edinburgh London Melbourne New York, pp 785–807
Emery AEH, Skinner R (1976) Clinical studies in benign (Becker type) X-linked muscular dystrophy. Clin Genet 10:189–201
Emery AEH, Holloway S (1977) Use of normal daughters' and sisters' creatine kinase levels in estimating heterozygosity in Duchenne muscular dystrophy. Hum Hered 27:118–126
Emery AEH, Burt D (1980) Intracellular calcium and pathogenesis and antenatal diagnosis of Duchenne muscular dystrophy. Br Med J 1:355–357
Emery AEH, Smith CAB, Sanger R (1968/1969) The linkage relations of the loci for benign (Becker type) X-borne muscular dystrophy, colour blindness and the Xg blood groups. Ann Hum Genet 32:261–269
Emery AEH, Watt MS, Clack ER (1972) The effects of genetic counselling in Duchenne muscular dystrophy. Clin Genet 3: 147–150
Emery AEH, Burt D, Dubowitz V, Rocker I, Donnai D, Harris R, Donnai P (1979a) Antenatal diagnosis of Duchenne muscular dystrophy. Lancet i:847–849
Emery AEH, Skinner R, Holloway S (1979b) A study of possible heterogeneity in Duchenne muscular dystrophy. Clin Genet 15:444–449
Engel WK (1967) Muscle biopsies in neuromuscular diseases. Pediatr Clin N Am 14:963–965
Engel WK (1971) Nouvelle hypothèse sur la pathogénie de la dystrophie musculaire pseudo-hypertrophique de Duchenne. Rev Neurol 124:291–298
Erb WH (1891) Dystrophia muscularis progressiva: Klinische und pathologisch anatomische Studien. Dtsch Z Nervenheilk 1:13–94
Eulenburg von A (1866) Ergebnisse der anatomischen Untersuchung eines Falles von sogenannter Muskelhypertrophie. Verhandl Berliner Med Gest 1:191
Falk RS, Campion D, Guthrie D, Sparkes RS, Fox CF (1979) Phosphorylation of red-cell membrane proteins in Duchenne muscular dystrophy. N Engl J Med 300:258–259
Fenichel GM (1975) On the pathogenesis of Duchenne muscular dystrophy. Dev Med Child Neurol 17:527–533
Ferrier P, Bamatter F, Klein D (1965) Muscular dystrophy (Duchenne) in a girl with Turner's syndrome. J Med Genet 2:38–46
Firth MA, Wilkinson EJ (1983) Screening the newborn for Duchenne muscular dystrophy: parents' view. Br Med J 286:1933–1934
Fischer S, Tortolero M, lau JP, Delauney J, Schapira G (1978) Protein kinase and adenylate cyclase or erythrocyte membrane proteins from patients with Duchenne muscular dystrophy. Clin Chim Acta 88:437–440
Fisher ER, Wissinger HA, Gerneth JA, Danowski TS (1972) Ultrastructural changes in skeletal muscle of muscular dystrophy carriers. Arch Pathol 94:456–460
Fisher ER, Silverstri E, Vester JW, Nolan S, Ahmed U, Danowski T (1976) Increased erythrocyte osmotic fragility in pseudohypertrophic muscular dystrophy. JAMA 236:955
Francke U, Felsenstein J, Gartler SM, Migeon BR, Dancis J, Seegmiller JE, Bakay F, Nyhan WL (1976) The occurrence of new mutants in the X-linked recessive Lesch-Nyhan disease. Am J Hum Genet 28:123–137
Francke U, Felsenstein J, Gartler SM, Nyhan WL, Seegmiller JE (1977) Answer to criticism of Morton and Laloue (Letter to the editor). Am J Hum Genet 29:307–310
Fritsch EF, Lawn RM, Maniatis T (1980) Molecular cloning and characterization of the human β-like globin gene cluster. Cell 19:959–972
Fuhrmann W, Vogel F (1982) Genetische Familienberatung. Ein Leitfaden für Studierende und Aerzte, 3. Aufl. Springer, Berlin Heidelberg New York
Gaines RF, Pueschel SM, Sassaman EA, Driscoll JL (1982) Effect of exercise on serum creatine kinase in carriers of Duchenne muscular dystrophy. J Med Genet 19:4–7
Gale AN, Murphy EA (1979) The use of serum creatine phosphokinase in genetic couseling for Duchenne muscular dystrophy. II: Review of methods of assay and factors which may be relevant in the interpretation of serum creatine phosphokinase activity. J Chron Dis 32:639–651
Gardner-Medwin D (1968) Studies of the carrier state in Duchenne type muscular dystrophy. Quantitative electromygraphy as a method of carrier detection. J Neurol Neurosurg Psychiatr 31: 121–134
Gardner-Medwin D (1970) Mutation rate in Duchenne type of muscular dystrophy. J Med Genet 7:334–337
Gardner-Medwin D (1979) Controversies about Duchenne muscular dystrophy. (1) Neonatal screening. Dev Med Child Neurol 21: 390–393
Gardner-Medwin D (1980) Clinical features and classification of the muscular dystrophies. Br Med Bull 36:109–115
Gardner-Medwin D, Pennington RJ, Walton JN (1971) The detection of carriers of X-linked muscular dystrophy genes. A review of some methods studied in Newcastle upon Tyne. J Neurol Sci 13:459–474
Gardner-Medwin D, Bundey S, Green S (1978) Early diagnosis of Duchenne muscular dystrophy. Lancet i:1102
Garceau C, Leblond PF, Lyonnais J, Beaupré A (1978) Morphologie et déformabilité des érythrocytes dans la dystrophie musculaire. Nouv Rev Fr Hématol Blood Cells 20:585–598
Gershwin ME, Taylor RG, Fowler WM, Finlayson B (1979) Failure to demonstrate abnormal lymphocyte capping in humans, mice and hamsters with muscular dystrophy. Hum Genet 53:113–114
Godin DV, Bridges MA, MacLeod PJM (1978) Chemical composition studies of erythrocyte membranes in Duchenne muscular dystrophy. Res Commun Chem Pathol Pharmacol 20:331–350
Golbus MS, Stephens JD, Mahoney MJ, Hobbins JC, Haseltine FP, Caskey CT, Banker BQ (1979) Failure of fetal creatine phosphokinase as a diagnostic indicator of Duchenne muscular dystrophy. N Engl J Med 300:860–861
Goldsmith BM, Gruemer HD, Hawley RJ, Pickard NA, Verril HL, Nance WE, Miller G, Crawford RG (1980) The contribution of assays for lymphocyte capping and creatine kinase to detection of the Becker-type dystrophy trait. Clin Chem 26:754–759
Gossens M, Dozy AM, Embyry SH, Zachariades Z, Hadjiminas MG, Stamatoyannopoulos G, Kan YW (1980) Triplicated α-globin loci in humans. Proc Natl Acad Sci 77:518–521
Gowers WR (1879) Pseudo-hypertrophic muscular paralysis. J A Churchill, London
Grassi E, Lucci B, Marchini C, Ottonello S, Parma M, Reggiani R, Rossi GL, Tagliavini J (1977) II problema delle alterazioni eritrocitarie (echnio e stomatocitche) nella distrofia muscolare. Ateno Parmense (Acta Biomed) 48:297–327
Grassi E, Lucci B, Marchini C, Ottonello S, Parma M, Reggiani R, Rossi GL, Tagliavini J (1978) Deformed erythrocytes in muscular dystrophies. Neurology 28:842–844
Greenstein RM, Reardon MP, Chan TS, Middleton AB, Mulivor RA, Green AE, Coriell LL (1980) An (X;11) translocation in a gril with Duchenne muscular dystrophy. Repository identification no. GM 1695. Cytogenet Cell Genet 27:268
Grimm T (1981) Neugeborenen-Screening nach Duchennescher Muskeldystrophie. Monatsschr Kinderheilk 129:414–417
Haldane JBS (1935) The rate of spontaneous mutation of a human gene. J Genet 31:317–326
Haldane JBS (1956) Mutation in the sex-linked recessive type of muscular dystrophy. A possible sex difference. Ann Hum Genet 20:344–347
Hammond DT, Jackson CE (1958) Consanguinity in a midwestern United States isolate. Am J Hum Genet 10:61–63
Hathaway PW, Engel WK, Zellweger H (1970) Experimental myopathy after microarterial embolization. Comparison with childhood X-linked pseudohypertrophic muscular dystrophy. Arch Neurol 22:365–377
Hauser SL, Weiner H, Ault K, Unanue E (1979a) Lymphocyte capping in muscular dystrophy. N Engl J Med 300:861
Hauser SL, Weiner HL, Bresnan MJ, Ault KA (1979b) Lymphocyte capping in muscular dystrophy. Neurology 29:1419–1421
Hausmanowa-Petrusewicz I, Prot J, Niebrój-Dobosz I (1968) Studies of healthy relatives of patients with Duchenne muscular dystrophy. J Neurol Sci 7:465–480
Hausmanowa-Petrusewicz I, Prot J, Dobosz I, Emeryk B, Roswinska K, Rubach K, Kopéc A, Kopéc J (1971) Further studies concerning the detection of carriership in the Duchhenne type of dystrophy. Eur Neurol 5:186–196
Hausmanowa-Petrusewicz I, Niebroj-Dobosz I, Borkowsak J, Lukasik E, Liszewska-Pfejfer D (1977) Carrier detection in Duchenne dystrophy. In: Rowland LP (ed) Pathogenesis of human muscular dystrophies. Amsterdam, Excerpta Medica, pp 32–41
Hausmanowa-Petrusewicz I, Wierzhicka M, Jozwik A, Szmidt-Salkowska E, Borkowska J (1982) A nearest neighbur decision rule for EMG detection of carriers of Duchenne muscular dystrophy. Electromyogr Clin Neurophysiol 22:445–457
Heller A (1866) Klinische Beobachtungen über die bisher als Muskelhypertrophie bezeichnete Lipomatosis luxurians musculorum progressiva. Dtsch Arch Klin Med 1:616
Herrmann FH, Spiegler A, Wiedemann G (1982) Muscle provocation test. A sensitive method for discrimination between carriers and noncarriers of Duchenne muscular dystrophy. Hum Genet 61:102–104
Herrmann J (1966) Der Einfluss des Zeugungsalters auf die Mutation zu Hämophilie A. Humangenetik 3:1–16
Heuch I, Li FHF (1972) PEDIG—a computer programme for calculation of genotype probabilities using phenotype information. Clin Genet 3:501–504
Heyck H, Laudahn G (1969) Die progressiv-dystrophischen Myopathien. Springer, Berlin
Hinderberger P, Moser H, Beck EA, Pflugshaupt R (1980) Heterozygotenerfassung bei der Hämophilie A—Genealogische und biochemische Resultate einer Feldstudie and 25 Bluterfamilien. Schweiz Rundschau Med (PRAXIS) 69:1349–1360
Ho AD, Reitter B, Stojakowits S, Fiehn W, Weisser J (1980a) Capping of lymphocytes for carrier detection in Duchenne muscular dystrophy: Technical problems and a review of the literature. Eur J Pediatr 134:211–216
Ho AD, Stojakowits S, Reitter B, Fiehn W, Zipperle G, Hunstein E, Lipinski CH (1980b) Capping of lymphocytes in patients and carriers of Duchenne muscular dystrophy. Klin Wschr 58:377–381
Hodson A, Pleasure D (1977) Erythrocyte cation-activated adenosine triphosphatases in Duchenne muscular dystrophy. J Neurol Sci 32:361–369
Horenstein AL, Emery AEH (1980) Human lymphocyte capping in Duchenne muscular dystrophy. Neurology 30:1330–1332
Howells KF (1976) Structural changes of erythrocyte membranes in muscular dystrophy. Res Exp Med 168:213–217
Howland JL, Iver SL (1977) Erythrocyte lipids in heterozygous carriers of Duchenne muscular dystrophy. Science 198:309–310
Hudgson P, Gardner-Medwin D, Pennington RJT, Walton JN (1967) Studies of the carrier state in the Duchenne type of muscular dystrophy. I. Effect of exercise on serum creatine kinase activity. J Neurol Neurosurg Psychiatry 30:416–419
Hughes RC, Park DC, Parsons ME, O'Brien MD (1971) Serum creatine kinase studies in the detection of carriers of Duchenne dystrophy. J Neurol Neurosurg Psychiatry 34:527–530
Hulten M, Luciani JM, Kirton V, Devictor-Vullet M (1978) The use and limitations of chiasma scoring with reference to human genetic mapping. Cytogenet Cell Genet 22:37–58
Hunsaker RH, Fulkerson PK, Barry FJ, Lewis RP, Leier CV, Unverferth DV (1982) Cardiac function in Duchenne's muscular dystrophy. Results of 10-year-follow-up study and noninvasive tests. Am J Med 73:235–238
Hunter MIS, Lao MS, de Vane PJ (1982) Is erythrocyte membrane phospholipid organisation abnormal in Duchenne muscular dystrophy. Clin Chim Acta 128:69–74
Hutton EM, Thompson MW (1976) Carrier detection and genetic counselling in Duchenne muscular dystrophy. A follow-up study. Can Med Ass J 115:749–752
Ionasescu V, Zellweger H (1974) Duchenne muscular dystrophy in young girls? Acta Neurol Scand 50:619–630
Ionasescu V, Zellweger H, Shirk P, Conway T (1973) Identification of carriers of Duchenne muscular dystrophy by muscle protein synthesis. Neurology 23:497–502
Ionasescu V, Radu H, Nicolescu P (1975) Identification of Duchenne muscular dystrophy carriers. Arch Pathol 99:436–441
Ionasescu V, Lara-Braud C, Zellweger H, Ionasescu R, Burmeister L (1977) Fibroblast cutures in Duchenne muscular dystrophy. Acta Neurol Scand 55:407–417
Ionasescu V, Zellweger H, Cancilla P (1978) Fetal serum creatine phosphokinase not a valid predictor of Duchenne muscular dystrophy. Lancet ii:1251
Ionasescu V, Burmeister L, Hanson J (1980) Discriminant analysis of ribosomal protein synthesis findings in carrier detection of Duchenne muscular dystrophy. Am J Med Genet 5:5–12
Iyer SL, Hoenig PA, Sherblom AP, Howland JL (1977) Membrance function affected by genetic muscular dystrophy. I. Erythrocyte ghost protein kinase. Biochem Med 18:384–391
Jackson CE, Carey JH (1961) Progressive muscular dystrophy: autosomal recessive type. Pediatrics 28:77–84
Jacobs PA, Hunt PA, Mayer M, Bart RD (1981) Duchenne muscular dystrophy (DMD) in a female with an X/autosome translocation: Further evidence that the DMD locus in at Xp21. Am J Hum Genet 33:513–518
Jalbert P, Mouriquand C, Beaudoing A, Jaillard M (1966) Myopathie progressive de type Duchenne et mosaique XO/XX/XXX: Considération sur la génèse de la fibre musculaire striée. Ann Génét 9:104–108
Jellett LB, Kennedy MC, Goldblatt E (1974) Duchenne pseudohypertrophic muscular dystrophy. A clinical and electrocardiographic study of patients and female carriers. Aust NZ J Med 4:41–47
Jerusalem F, Engel AG, Gomez MR (1974a) Duchenne dystrophy: Morphometric study of the muscle microvasculature. Brain 97: 115–122
Jerusalem F, Engel AG, Gomez MR (1974b) Duchenne dystrophy: II. Morphometric study of motor end-plate fine structure. Brain 97:123–130
Johnston HA (1964) Severe muscular dystrophy in girls. J Med Genet 1:79–81
Jones GE, Witkowski JA (1979) Reduced adhesiveness between skin fibroblasts from patients with Duchenne muscular dystrophy. J Neurol Sci 43:465–470
Jones GE, Witkowski JA (1981) Analysis of skin fibroblasts from patients with Duchenne muscular dystrophy. J Cell Sci 48: 291–300
Jones GE, Witkowski JA (1983a) Membrane abnormalities in Duchenne muscular dystrophy. J Neurol Sci 58:159–174
Jones GE, Severs NJ, Witkowski JA (1983) Freeze-fracture analysis of plasma membranes in Duchenne muscular dystrophy. A study using cultured skin fibroblasts. J Neurol Sci 58:185–193
Jones GE, Witkowski JA (1983b) A cell surface abnormality in Duchenne muscular dystrophy: intercellular adhesiveness of skin fibroblatts from patients and carriers. Hum Genet 63:232–237
Jones KW (1980) Muscle cell differentiation and the prospects for the genetic engineering. Br Med Bull 36:173–180
Kalofoutis A, Jullien G, Spanos V (1977) Erythrocyte phospholipids in Duchenne muscular dystrophy. Clin Chim Acta 74:85–87
Kar NC, Pearson CM (1976) Ca-activated neutral protease in normal and dystrophic human muscle. Clin Chim Acta 73:293–297
Kar NC, Pearson CM (1978) Muscular dystrophy and activation of proteinases. Muscle and Nerve 1:308–313
Khoklov AP, Malakhovsky VK (1978) Characteristics of cyclic 3′,5′-AMP turnover in patients with progressive muscular atrophy. Vopr Med Khim 27:754–758
Kim HD, Luthra MG, Watts RP, Stern LZ (1979) Factors influencing osmotic fragility of Duchenne red blood cells. Ann Neurol 6:153
Kingston HM, Thomas NST, Pearson PL, Sarfarazi M, Harper PS (1983) Genetic linkage between Becker muscular dystrophy and a polymorphic DNA sequence on the short arm of the X chromosome. J Med Genet 20:255–258
Klassen GA, Blostein R (1969) Adenosine triphosphatase and myopathy. Science 163:492–493
Kloepfer HW, Talley C (1958) Autosomal recessive inheritance of Duchenne type muscular dystrophy. Ann Genet 22:138–143
Kobayashi T, Mawatari S, Kuroiwa Y (1978) Lipids and proteins of erythrocyte membrane in Duchenne muscular dystrophy. Clin Chim Acta 85:259–266
Koehler JP (1974) Blood vessel structure in Duchenne muscular dystrophy. Neurology 24:354
Kohlschütter A, Wiesmann UN, Herschkowitz NN, Ferber E (1976) Phospholipid composition of cultivated skin fibroblasts in Duchenne muscular dystrophy. Clin Chim Acta 70:463–465
Koski CL, Jungalwala FB, Kolodny EH (1978) Normality of erythrocyte phospholipids in Duchenne muscular dystrophy. Clin Chim Acta 85:295–298
Kosower D, Christiansen R, Morton NE (1962) Sporadic cases of hemophilia and the question of a possible sex-difference in mutations. Am J Hum Genet 14:159–169
Kuby SA, Keutel HJ, Okabe K, Jacobs HK, Ziter F, Gerber D, Tyler FH (1977) Isolation of human ATP-creatine transphosphorylases (creatine phosphokinases) from tissues of patients with Duchenne muscular dystrophy. J Biol Chem 252:8382–8390
Kuby SA, Palmieri RH, Okabe K, Frischat A, Cress MC (1979) Studies on muscular dystrophy: a comparison by physical and chemical means of the normal human ATP-creatine transphosphorylases (creatine kinases) with those from tissues in Duchenne dystrophy. Arch Biochem Biophys 194:236–253
Kunze D, Reichmann G, Egger E, Leuschner G, Eckhardt H (1973) Erythrozytenlipide bei progressiver Muskeldystrophie. Clin Chim Acta 43:333–341
Kuroiwa Y, Miyazaki T (1967) Epidemiological study of myopathy in Japan. In: Milhorat AT (ed) Exploratory concepts in muscular dystrophy and related disorders. Excerpta Medica, Amsterdam. Int Congr Ser 147, p 98
Lane RJM, Maskrey P, Nicholson GA, Siddiqui PQR, Nicholson M, Gascoigne P, Pennington RJT, Gardner-Medwin D, Walton JN (1979) An evaluation of some carrier detection techniques in Duchenne muscular dystrophy. J Neurol Sci 43:377–394
Lane RJM, Gardner-Medwin D, Roses AD (1980) Electrocardiographic abnormalities in carriers of Duchenne muscular dystrophy. Neurology 30:497–501
Lane RJM, Robinow M, Roses AD (1983) The genetic status of mothers of isolated cases of Duchenne muscular dystrophy. J Med Genet 20:1–11
Lange K, Zatz M (1979) A new method for the analysis of age trends in CPK levels with application to Duchenne muscular dystrophy. Hum Hered 29:154–160
Leder P (1978) Discontinuous genes. N Engl J Med 298:1079–1081
Leibowitz D, Dubowitz V (1981) Intellect and behaviour in Duchenne muscular dystrophy. Dev Med Child Neurol 23:577–590
Liechti-Gallati S, Moser H, Siegrist HP, Wiesmann U, Herschkowitz NN (1981) Abnormal growth kinetics and 5′-nucleotidase activities in cultured skin fibroblasts from patients with Duchenne muscular dystrophy. Pediatr Res 15:1411–1414
Lindenbaum RH, Clarke G, Patel C, Moncrieff M, Hughes JT (1979) Muscular dystrophy in an X;1 translocation female suggests that Duchenne locus is on X chromosome short arm. J Med Genet 16:389–392
Little WJ (1853) On the nature and treatment of the deformities of the human frame: being a course of lectures delivered at the Royal Orthopaedic Hospital in 1843: With numerous notes and additions to the present time. Longman, Brown, Greene & Longmans, pp 14–16
Lloyd SJ (1978) Osmotic fragility of erythrocytes in Duchenne muscular dystrophy. Br Med J 2:252
Lyon MF (1962) Sex chromatin and gene action in the mammalian X-chromosome. Am J Hum Genet 14:135–148
Mahoney MJ, Haseltine FP, Hobbins JC, Banker BQ, Caskey CT, Golbus MS (1977) Prenatal diagnosis of Duchenne's muscular dystrophy. N Engl J Med 297:968–973
Marsh GG, Munsat TL (1974) Evidence for early impairment of verbal intelligence in Duchenne muscular dystrophy. Arch Dis Child 49:118–122
Matheson DW, Howland JL (1974) Erythrocyte deformation in human muscular dystrophy. Science 184:165–166
Matheson DW, Howland JL (1975) Erythrocytes in human muscular dystrophy. Science 187:453–454
Maunder-Sewry CA, Dubowitz V (1981) Needle muscle biopsy for carrier detection in Duchenne muscular dystrophy. Part 1. Light microscopy-histology, histochemistry and quantitation. J Neurol Sci 49:305–324
Mawatari S, Takagi A, Rowland LP (1974) Adenyl cyclase in normal and pathological human muscle. Arch Neurol 30:96–102
Mawatari S, Miranda A, Rowland LP (1976a) Adenyl cyclase abnormality in Duchenne muscular dystrophy: muscle cells in culture. Neurology 26:1021–1026
Mawatari S, Schonberg M, Olarte M (1976b) ATPase and adenyl cyclase in erythrocytes of patients with Duchenne muscular dystrophy. Arch Neurol 33:489–493
Mawatari S, Igisu H, Kuroiwa Y, Miyoshino S (1981) Na+K+ATPase of erythrocyte membranes in Duchenne muscular dystrophy. Neurology 31:293–297
McComas AJ, Sica REP, Currie S (1970) Muscular dystrophy: evidence for a neural factor. Nature 226:1263–1264
McComas AJ, Sica REP, Campbell MJ (1971a) An electrophysiological study of Duchenne dystrophy. J Neurol Neurosurg Psychiatry 34:461–468
McComas AJ, Sica REP, Campbell MJ (1971b) “Sick” motoneurones: A unifying concept of muscle disease. Lancet i:321–325
McComas AJ, Sica REP, Upton ARM (1974) Multiple analysis of motor units in muscular dystrophy. Arch Neurol 30:249–251
McLaughlin J, Engel WK (1979) Lipid composition of erythrocytes. Finding in Duchenne's muscular dystrophy and myotonic atrophy. Arch Neurol 36:351–354
McMurchie EJ, Williams RE, Sparkes RS, Fox CF (1979) Altered cell surface organization in cultured Duchenne muscular dystrophic fibroblasts. Proc Aust Biochem Soc 12:30
Mendell JR, Engel WK, Derrer EC (1971) Duchenne muscular dystrophy: Functional ischemia reproduces its characteristic lesions. Science 172:1143–1145
Meryon E (1852) On granular and fatty degeneration of the voluntary muscles. Med Chir Trans 35:73–84
Meryon E (1864) Practical and pathological researches on the various forms of paralysis. Churchill, London
Miale TP, Frias JL, Lawson DL (1975) Erythrocytes in human muscular dystrophy. Science 187:453–454
Milhorat AT, Goldstone L (1965) The carrier state in muscular dystrophy of the Duchenne type. JAMA 194:130–134
Miller SE, Roses AD, Appel SH (1975) Erythrocytes in human muscular dystrophy. Science 188:1131
Miller SE, Roses AD, Appel SH (1976) Scanning electron microscopy studies in muscular dystrophy. Arch Neurol 33:172–174
Miyoshi K, Saito S, Kawai H, Kondo A, Iwasa M, Hayashi T, Yagita M (1978) Radioimmunoassay for human myoglobin: Methods and results in patients with skeletal muscle or myocardial disorders. J Lab Clin Med 92:341–352
Mokri B, Engel AG (1975) Duchenne dystrophy: Electronmicroscopic findings pointing to a basic or early abnormality in the plasma membrane of the muscle fiber. Neurology 25:1111–1120
Monckton G, Marusyk H, Pehowich E (1981) A method for the detection of carriers of Duchenne muscular dystrophy—A preliminary report. Am J Hum Genet 33:978–986
Monckton G, Hoskin V, Warren S (1982) Prevalence and incidence of muscular dystrophy in Alberta, Canada. Clin Genet 21:19–24
Moosa A, Brown BH, Dubowitz V (1972) Quantitative electromyography: carrier detection in Duchenne type muscular dystrophy using a new automatic technique. J Neurol Neurosurg Psychiatry 35:841–844
Morris CJ, Raybould JA (1971) Histochemically demonstrable fibre abnormalities in normal skeletal muscle and in muscle from carriers of Duchenne muscular dystrophy. J Neurol Neurosurg Psychiatry 34:348–352
Morris GE, Buzash EA, Bourke AW, Tepperman K, Thompson WC, Heywood SM (1973) Myosin messenger RNA: Studies on its purification, properties and translation during myogenesis in culture. In: The mechanism of muscle contraction. Cold Spring Harbor Symp Quant Biol 37:535–541
Morton NE (1958) Segregation analysis in human genetics. Science 127:79–80
Morton NE, Chung CS (1959) Formal genetics of muscular dystrophy. Am J Hum Genet 11:360–379
Moser H (1976/1977) Bestimmung der Heterozygotenwahrscheinlichkeit bei Angehörigen „sporadischer” Fälle X-chromosomal-rezessiver Erbleiden. Arch Genet 49/50:113–126
Moser H (1977) Heterozygotenerfassung und genetische Beratung bei der progressiven Muskeldystrophie Duchenne. Schweiz Rundschau Med (PRAXIS) 66:814–822
Moser H (1983) Unpublished data
Moser H, Wiesmann U (1971) Serum-Creatin-Kinase und Sulfhydrilarmmuskulatur bei Patienten und Konduktorinnen der progressiven Muskeldystrophie Duchenne. Klin Wschr 49:488–494
Moser H, Emery AEH (1974) The manifesting carrier in Duchenne muscular dystrophy. Clin Genet 5:271–284
Moser H, Vogt J (1974) Follow-up study of serum-creatine-kinase in carriers of Duchenne muscular dystrophy. Lancet ii:661–662
Moser H, Wiesmann U, Richterich R, Rossi E (1964) Progressive Muskeldystrophie. VI. Häufigkeit, Klinik und Genetik der Duchenne-Form. Schweiz Med Wschr 95:1610–1621
Moser H, Mumenthaler M, Wiesmann U (1971) Biochemische, histologische und klinische Befunde bei Konduktorinnen der progressiven Muskeldystrophie vom Typ Duchenne. Schweiz Med Wschr 101:537–542; 573–578
Munsat TL, Bradley WG (1977) Serum creatine phosphokinase levels and prednisone-treated muscle weakness. Neurology 27:96–97
Munsat TL, Baloh R, Pearson CM, Fowler W Jr (1973) Serum enzyme alterations in neuromuscular disorders. JAMA 226:1536–1542
Murphy EA, Mutalik GS (1969) The application of Bayesian methods in genetic counselling. Hum Hered 19:126–151
Murphy EA, Chase GA (1975) Principles of genetic counseling. Year Book Med Publ, Chicago
Murphy EG, Corey PNJ, Conen PE (1964) Varying manifestations of Duchenne muscular dystrophy in a family with affected females. In: Paul WM, Daniel EE, Kay CM, Monckton G (eds) Muscle (Proceedings of Symposium at Faculty of Medicine, University of Alberta). Pergamon, New York, pp 529–546
Murray JM, Davies KE, Harper PS, Meredith L, Mueller CR, Williamson R (1982) Linkage relationship of a cloned DNA sequence on the short arm of the X chromosome to Duchenne muscular dystrophy. Nature 300:69–71
Nicholson LVB (1981) Serum myoglobin in muscular dystrophy and carrier detection. J Neurol Sci 51:411–426
Nicholson GA, Sugars J (1982a) Decreased A 23187-induced chemiluminiscence in Duchenne muscular dystrophy granulocytes. J Neurol Sci 56:11–16
Nicholson GA, Sugars J (1982b) An evaluation of lymphocyte capping in Duchenne muscular dystrophy. J Neurol Sci 53:511–518
Nicholson GA, Gardner-Medwin G, Pennington RJT, Walton JN (1979) Carrier detection in Duchenne muscular dystrophy: Assessment of the effect of age on detection-rate with serum-creatine-kinase-activity. Lancet i:692–694
Nicholson GA, Lane RJM, Gardner-Medwin D, Walton JN (1981) Carrier testing in families of isolated cases of Duchenne muscular dystrophy. Creatine kinase activities in female relatives of mothers with normal CK activity. J Neurol Sci 51:29–42
Niebroj-Dobosz I (1976) Erythrocyte ghosts (Na+K+) ATPase activity in Duchenne's dystrophy and myotonia. J Neurol 214:61–69
Nomura H, Hizawa K (1982) Histopathological study of the conduction system of the heart in Duchenne progressive muscular dystrophy. Acta Pathol Jpn 32:1027–1033
Nordal HJ, Andersson TR, Dietrichson P (1982) Lymphocyte capping: A diagnostic method in progressive muscular dystrophy? Acta Neurol Scand 65:442–447
Nørregaard-Hansen K, Sørensen OH (1982) Significance of serum myoglobin in neuromuscular diseases and in carrier-detection of Duchenne muscular dystrophy. Acta Neurol Scand 66:259–266
Oberc MA, Engel WK (1977) Ultrastructural localization of calcium in normal and abnormal skeletal muscle. Lab Invest 36:566–577
O'Brien T, Harper PS, Davies KE, Murray JM, Sarfarazi M, Williamson R (1983) Absence of genetic heterogeneity in Duchenne muscular dystrophy shown by a linkage study using two cloned DNA sequences. J Med Genet 20:249–251
Olson BJ, Fenichel GM (1982) Progressive muscle disease in a young woman with family history of Duchenne's muscular dystrophy. Arch Neurol 39:378–380
Osame M, Engel AG, Rebouche CJ, Scott RE (1981) Freeze-fracture electron microscopic analysis of plasma membranes of cultured muscle cells in Duchenne dystrophy. Neurology 31:972–979
Panayiotopoulos CP (1974) Electrophysiological estimation of motor units in Duchenne muscular dystrophy. J Neurol Sci 23:89–98
Paterson BM, Bishop JO (1977) Changes in the mRNA population of chick myoblasts during myogenesis in vitro. Cell 12:751–765
Paulson OB, Engel AG, Gomez MR (1974) Muscle blood flow in Duchenne type muscular dystrophy, limb-girdle dystrophy, polymyositis, and in normal controls. J Neurol Neurosurg Psychiatry 37:685–690
Pearce GW, Pearce JMS, Walton JN (1966) The Duchenne type muscular dystrophy: Histopathological studies of the carrier state. Brain 89:109–120
Pearce JMS, Pennington RJT, Walton JN (1964) Serum enzyme studies in muscle disease. Part III. Serum creatine kinase activity in relatives of patients with the Duchenne type of muscular dystrophy. J Neurol Neurosurg Psychiatry 27:181–185
Pearson CM (1962) Histopathological features of muscle in the preclinical stages of muscular dystrophy. Brain 85:109–120
Pearson CM, Fowler WM, Wright SW (1963) X-chromosome mosaicism in females with muscular dystrophy. Proc Natl Acad Sci 50:24–31
Pearson TW (1978) (Na++K+)-ATPase of Duchenne muscular dystrophy erythrocyte ghosts. Life Sci 22:127–132
Pena DJ (1978) Is Duchenne muscular dystrophy a simple genic disorder? Lancet ii:630
Penn AS, Lisak RP, Rowland P (1970) Muscular dystrophy in young girls. Neurology 20:147–159
Penn AS, Cloak EA, Rowland LP (1972) Myosin from normal and dystrophic human muscle: immunchemical and electrophoretic studies. Arch Neurol 27:159–173
Pennington RJT (1977) Proteinases of muscle. In: Barrett AJ (ed) Proteinases in mammalian cells and tissues. Amsterdam, North Holland Publishing Co, pp 515–543
Penrose LS (1955) Parental age and mutation. Lancet ii:312–313
Percy ME, Chang LS, Murphy EG, Oss I, Verellen-Dumoulin C, Thompson MW (1979) Serum creatine kinase and pyruvate kinase in Duchenne muscular dystrophy carrier detection. Muscle and Nerve 2:329–339
Pestronk A, Parhad IM, Drachman DB, Price DL (1982) Membrane myopathy: Morphological similarities to Duchenne muscular dystrophy. Muscle and Nerve 5:209–214
Peter JB, Worsfold M (1969) Muscular dystrophy and other myopathies: sarcotubular vesicles in early disease. Biochem Med 2:364–371
Peter JB, Worsfold M, Pearson CM (1969) Erythrocyte ghost adenosine triphosphatase in Duchenne dystrophy. J Lab Clin Med 74:103–108
Peter JB, Fiehn W, Nagamoto T, Andiman R, Stempel K, Bowman R (1974) Studies of sarcolemma from normal and diseased skeletal muscle. In: Milhorat AT (ed) Exploratory concepts in muscular dystrophy II. Amsterdam, Excerpta Medica, pp 479–490
Pfändler U (1950) Eine einfach rezessive Form der Dystrophia musculorum progressiva mit einer Sippenstammtafel aus dem Emmental (Schweiz). Dtsch Med Wschr 75:1221–1225
Pickard NA, Gruemer HD, Verrill HL, Isaacs ER, Robinow M, Nance WE, Myers EC, Goldsmith B (1978) Systemic membrane defect in the proximal muscular dystrophies. N Engl J Med 299:841–846
Pirro R, Lauro R, Testa I, Ferretti G, De Martinis C, Dellantonio R (1982) Decreased insulin receptors but normal glucose metabolism in Duchenne muscular dystrophy. Science 216:311–313
Price R (1763) An essay towards solving a problem in the doctrine of chances. By the late Rev. Mr. Bayes. F.R.S. Philos Trans R Soc Lond 53:370–375
Prot J (1971) Genetic-epidemiologic studies in progressive muscular dystrophy. J Med Genet 8:90–96
Prosser EJ, Murphy EG, Thompson MW (1969) Intelligence and the gene for Duchenne muscular dystrophy. Arch Dis Child 44:221–230
Proudfoot NJ, Maniatis T (1980) The structure of human α-globin pseudogene and its relationship to α-globin gene duplication. Cell 21:537–544
Radu H, Stenzel K (1969) Beiträge zum Studium der pseudohypertrophischen Muskeldystrophien. II. Pseudohypertrophische Muskeldystrophie bei Mädchen. Dtsch Z Nervenheilk 196:116–135
Radu H, Migea S, Tötök A, Bordeianu L, Radu A (1968) Carrier detection in X-linked Duchenne type muscular dystrophy. Pluridimensional investigation. J Neurol Sci 6:289–300
Rao GA, Siler K, Larkin EC (1978) Palmitoleic acid in erythrocytes from carriers of Duchenne muscular dystrophy. Science 200:1416
Ratnoff O, Jones PK (1977) The laboratory diagnosis of the carrier state for classic hemophilia. Ann Int Med 86:521–528
Ritossa FM, Atwood KC, Spiegleman S (1966) A molecular explanation of the bobbed mutants of Drosophila as partial deficiencies of ribosomal DNA. Genetics 54:819–834
Robinson L (1979) Split genes and muscular dystrophy. Muscle and Nerve 2:458–464
Rodan GA, Rodan SB, Raible DG, Cutler LS, Wacholtz M, Sha'ari RI (1979) Adenylate cyclase in muscular dystrophy. Ann NY Acad Sci 317:670–691
Rodemann HP (1979) Die molekularen Mechanismen des pathophysiologischen Alterns: Untersuchungen an Hautfibroblasten von Patienten mit Duchenne-Muskeldystrophie. Dissertation, Stuttgart-Hohenheim
Rosenmann E, Kreis C, Thompson RG, Dobbs M, Hamerton JL, Wrogeman K (1982) Analysis of fibroblast proteins from patients with Duchenne muscular dystrophy by two-dimensional gel electrophoresis. Nature 298:563–565
Roses AD (1979) Erythrocyte membranes autophosphorylation in Duchenne muscular dystrophy: effect of two methods of ghost preparation on results. Clin Chim Acta 95:69–74
Roses AD, Appel SH (1976) Erythrocyte spectrin peak II phosphorylation in Duchenne muscular dystrophy. J Neurol Sci 29:185–193
Roses AD, Herbstreith M, Metcalf B, Appel SH (1976a) Increased phosphorylated components of erythrocyte membrane spectrin band II with reference to Duchenne dystrophy. J Neurol Sci 30:167–178
Roses AD, Roses MJ, Miller SE, Hull KL, Appel SH (1976b) Carrier detection in Duchenne muscular dystrophy. N Engl J Med 294:193–198
Roses AD, Roses MJ, Metcalf BS, Hull KL, Nicholson GA, Hartwig GB, Roe CR (1977) Pedigree testing in Duchenne muscular dystrophy. Ann Neurol 2:271–278
Roses AD, Hartwig GB, Mabry M, Nagano Y, Miller SE (1980) Red blood cell and fibroblast membranes in Duchenne and myotonic muscular dystrophy. Muscle and Nerve 3:36–54
Roses AD, Shile PE, Herbstreith MH, Balakrishnan CV (1981) Identification of abnormally (32P)-phosphorylated cyanogen bromide cleavage product of erythrocyte membrane spectrin in Duchenne muscular dystrophy. Neurology 31:1026–1030
Roses MS, Nicholson MT, Kircher CS, Roses AD (1977) Evaluation and detection of Duchenne's and Becker's muscular dystrophy carriers by manual muscle testing. Neurology 27:20–25
Rott HD, Mulz D (1982) Muskeldystrophie Duchenne: Konduktorinnenerfassung mit Ultraschall. Dtsch med Wschr 107:1678–1681
Rott HD, Mulz D (1983) Duchenne's muscular dystrophy: Carrier detection by muscle ultrasound. J Génét Hum 31:63–65
Rowland LP (1976) pathogenesis of muscular dystrophies. Arch Neurol 33:315–321
Rowland LP (1980) Biochemistry of muscle membranes in Duchenne muscular dystrophy. Muscle and Nerve 3:3–20
Rowland LP, Osnos M, Hirschberg E (1960) Serum enzymes in the myopathies. Trans Am Neurol Assoc 85:15–18
Roy S, Dubowitz V (1970) Carrier detection in Duchenne muscular dystrophy. A comparative study of electron microscopy, light microscopy and serum enzymes. J Neurol Sci 11:65–79
Ruitenbeek W (1978a) The fatty acid composition of various lipid fractions isolated from erythrocytes and blood plasma of patients with Duchenne and congenital myotonic muscular dystrophy.Clin Chim Acta 89:99–110
Ruitenbeek W (1979) Membrane-bound enzymes of erythrocytes in human muscular dystrophy: (Na++K+)-ATPase, Ca++-ATPase, K+- and Ca++-p-nitrophenylphosphatase. J Neurol Sci 41:71–80
Ruitenbeek W, Edixhoven MJ, Scholte HR (1978b) Osmotic stability of erythrocytes in human muscular dystrophy before and after phospholipase treatment. Clin Chim Acta 94:259–266
Sage J, Inati Y, Samaha F (1979) The importance of serum pyruvate kinase in neuromuscular diseases and carrier states. Muscle and Nerve 2:390–393
Samaha FJ (1972) Tropomyosin and troponin in normal and dystrophic human muscle. Arch Neurol 26:547–550
Samaha FJ, Gergely J (1969) Biochemical abnormalities of the sarcoplasmic reticulum in muscular dystrophy. N Engl J Med 280:184–188
Samaha FJ, Congedo CZ (1977) Two biochemical types of Duchenne dystrophy: sarcoplasmic reticulum membrane proteins. Ann Neurol 1:125–130
Samaha FJ, Thies WH (1979) Myosin light chains in Duchenne dystrophy and paraplegic muscle. Neurology 29:122–125
Sands ME, Harris R (1979) Lymphocyte capping and carrier detection rate in Duchenne muscular dystrophy. Lancet ii:698
Sanyl SK, Johnson WW (1982) Cardiac conduction abnormalities in children with Duchenne's progressive muscular dystrophy: Electrocardiographic features and morphologic correlates. Circulation 66:853–863
Satapathy RK, Skinner R (1979) Serum creatine kinase levels in normal females. J Med Genet 16:49–51
Sato B, Nishikida K, Samuels LT, Tyler FH (1978) Electron spin resonance studies of erythrocytes from patients with Duchenne muscular dystrophy. J Clin Invest 61:251–259
Scarlato G, Meola G, Silani V, Manfredi L, Bottiroli G, Zanella A (1979) Erythrocyte spectrofluorometric abnormalities in Duchenne patients and carriers. A new approach to carrier detection. Acta Neurol Scand 59:262–269
Scarpalezos S, Panayiotopoulos CP (1973) Duchenne muscular dystrophy: Reservations to the neurogenic hypothesis. Lancet ii:458
Shay JW, Cook J, Fuseler JW (1979a) Microtubules and Duchenne muscular dystrophy. Ann Neurol 6:147
Shay JW, Fuseler JW (1979b) Diminished microtubules in fibroblast cells derived from inherited dystrophic muscle explants. Nature 278:178–180
Shoji S (1981) Calcium flux of erythrocytes in Duchenne muscular dystrophy. J Neurol Sci 51:427–435
Sica REP, McComas AJ (1978) The neural hypothesis of muscular dystrophy. A review of recent experimental evidence with particular reference to the Duchenne form. Can J Neurol Sci 5:189–197
Siddiqui QR, Pennington RJT (1977) Effect of ouabain upon erythrocyte membrane adenosine triphosphatase in Duchenne muscular dystrophy. J Neurol Sci 34:365–372
Silverman LM, Gruemer HD (1976) Sarcolemmal membrane changes related to enzyme release in the imipramine/serotonin experimental animal model. Clin Chem 22:1710–1714
Skinner R, Smith C, Emery AEH (1974) Linkage between the loci for benign (Becker-type) X-borne muscular dystrophy and deutan colour blindness. J Med Genet 11:317–320
Skinner R, Emery AEH, Scheuerbrandt G, Syme J (1982) Feasibility of neonatal screening for Duchenne muscular dystrophy. J Med Genet 19:1–3
Skyring A, McKusick V (1961) Clinical, genetic and electrocardiographic studies in childhood muscular dystrophy. Am J Med Sci 242:534–547
Slightom JL, Blechl AE, Smithies O (1980) Human fetal Gγ- and Aγ-globin genes: Complete nucleotide sequences suggest that DNA can be exchanged between these duplicated genes. Cell 21:627–638
Smith CAB, Kilpatrick SJ (1958) Estimates of the sex ratio of mutation rates in sex-linked conditions by the method of maximum likelihood. Ann Hum Genet 22:244–249
Smith I, Elton RA, Thomson WHS (1979) Carrier detection in X-linked recessive (Duchenne) muscular dystrophy: Serum creatine phosphokinase values in premenarchal menstruating, postmenopausal and pregnant normal women. Clin Chim Acta 98:207–216
Soltan HC (1977) Echinocytes in families with Duchenne dystrophy. J Med Genet 14:276–278
Somer H, Olarte M (1977) Red blood cells in Duchenne muscular dystrophy: increased osmotic fragility, lack of increased enzyme leakage. Neurology 27:361
Somer H, Chien S, Sung LA, Thurn A (1979) Erythrocytes in Duchenne dystrophy: osmotic fragility and membrane deformability. Neurology 29:519–522
Souweine G, Bernard JC, Lasne Y, Lachanat J (1978) The sodium pump of erythrocytes from patients with Duchenne muscular dystrophy: effects of ouabain on the active sodium flux and on (Na+, K+)ATPase. J Neurol 217:287–294
Spiegler A, Wiedemann G, Herrmann FH, Menzel K, Hoffmann W (1982) Altersabhängigkeit der Creatinkinase-(CK-) Aktivität im Serum: Referenzwerte zur Konduktorinnendiagnostik bei Duchenne-Muskeldystrophie (DMD). Dtsch Gesundheitswesen 37:2009–2013
Spowart G, Buckton KE, Skinner R, Emery AEH (1982) X-chromosome in Duchenne muscular dystrophy. Lancet i:1251
Sugita H, Tyler FH (1963) Pathogenesis of muscular dystrophy. Trans Assoc Am Physicians 76:231–244
Sugita H, Okimoto K, Ebashi S, Okinaka S (1967) Biochemical alterations in progressive muscular dystrophy with special reference to the sarcoplasmic reticulum. In: Milhorat AT (ed) Exploratory concepts in muscular dystrophy and related disorders. Amsterdam, Excerpta Medica Foundation, p 321
Susheela AK, Kaul RD, Sachdev K, Singh N (1975) Adenyl cyclase activity in Duchenne dystrophic muscle. J Neurol Sci 24:361–363
Sybert VP, Setran KN, Kadin ME (1979) Lymphocyte capping in carriers of Duchenne muscular dystrophy. N Engl J Med 301:724–725
Schapira G, Dreyfus JC, Schapira F (1953) L'élévation du taux de l'aldolase sérique: test biochimique de myopathies. Sem Hôp Paris 29:1917–1921
Schmalbruch H (1975) Segmental fibre breakdown and defects of the plasmalemma in diseased human muscles. Acta Neuropathol 33:129–141
Schmalbruch H (1979) A freeze-fracture study of the plasma membrane of muscle fibers of a patient with chronic creatine kinase elevation suspected for malignant hyperthermia. J Neuropathol Exp Neurol 38:407–418
Scholte HR, Busch HMF (1979) 5′-nucleotidase activity in Duchenne muscular dystrophy. N Engl J Med 301:726
Scholte HR, Busch HFM (1980) Decreased phosphorylase activity in leucocytes of Duchenne carriers. Clin Chim Acta 105:137–139
Schotland DL, Bonilla E, Wakayama Y (1981) Freeze-fracture studies of muscle plasma membrane in human muscular dystrophy. Acta Neuropathol 54:189–197
Statham HE, Witkowsky JA, Dubowitz V (1979) Protein degradation in skin fibroblasts from patients with Duchenne muscular dystrophy. Biochem J 192:257–262
Statham HE, Dubowitz V (1979) Duchenne muscular dystrophy: 45Ca exchange in cultured skin fibroblasts and the effect of calcium ionophore A 23187. Clin Chim Acta 96:225–231
Stengel-Rutkowski L, Scheuerbrandt G, Beckmann R, Pongratz D (1977) Prenatal diagnosis of Duchenne's muscular dystrophy. Lancet i:1359–1360
Stephens FE, Tyler FH (1951) Studies in disorders of muscle. V. The inheritance of childhood progressive muscular dystrophy in 33 kindreds Am J Hum Genet 3:111–125
Stephens J, Lewin E (1965) Serum enzyme variations and histological abnormalities in the carrier state in Duchenne dystrophy. J Neurol Neurosurg Psychiatry 28:104–108
Stern LM (1972) Four cases of Duchenne-type muscular dystrophy in girls. Med J Aust 2:1066–1069
Stern CMM, Kahan MC, Dubowitz V (1979) Lymphocyte capping in Duchenne muscular dystrophy. Lancet i:1300
Stevenson AC (1958) Muscular dystrophy in Northern Ireland. IV. Some additional data. Ann Hum Genet 22:231–234
Takagi A, Schotland DL, Rowland LP (1973) Sarcoplasmic reticulum in Duchenne dystrophy. Arch Neurol 28:380–384
Takahashi K, Takao H, Takai T (1978) Adenylate cyclase in Duchenne and Fukuyama type muscular dystrophy. Kobe J Med Sci 24:193–198
Tartof KD (1975) Redundant genes. Ann Rev Genet 9:355–385
Ten Kate LP, Offringa PJ (1981) The significance of different types of information in calculating the probability that a female relative of a Duchenne muscular dystrophy patient is a carrier. Clin Genet 20:281–288
Testard R, Mendolia M, Larget-Piet L, Williamson C, Delaitre R (1973) A propos d'une myopathie de Duchenne de Boulogne chez une fille. Ouest Méd Paris 26:1175–1178
Thompson CE (1978) Reproduction in Duchenne dystrophy. Neurology 28:1045–1047
Thompson RG, Sponder ES, Rosenmann E, Hamerton JL, Wrogeman K (1982) Proline incorporation by cultured skin fibroblasts from patients with Duchenne muscular dystrophy. J Neurol Sci 57:41–54
Thomson WHS (1969) The biochemical identification of the carrier state in X-linked recessive (Duchenne) muscular dystrophy. Clin Chim Acta 26:207–221
Thomson WHS (1979) Carrier-detection rate and age in Duchenne muscular dystrophy. Lancet i:829
Thomson WHS, Sweeting JC, Hamilton IJD (1975) ATP and muscle enzyme efflux after physical exertion. Clin Chim Acta 59:241–245
Tomkins JK (1980) The molecular defect in Duchenne muscular dystrophy. Muscle and Nerve 3:529–530
Tomlinson BE, Walton JN, Irving D (1974) Spinal cord limb motor neurones in muscular dystrophy. J Neurol Sci 22:305–327
Tzvetanova E (1971) Aldolase isoenzymes in serum and muscle from patients with progressive muscular dystrophy and from human foetus. J Neurol Sci 14:483–489
Valli G, Scarlato G, Contartese M (1976) Quantitative electromyography in the detection of the carriers in Duchenne type muscular dystrophy. J Neurol 212:139–149
Vasiljevic ZM, Polic DD (1983) Morphological changes of erythrocytes in patients and carriers of Duchenne disease. Acta Neurol Scand 67:242–244
Vassella F, Richterich R, Rossi E (1965) The diagnostic value of serum creatine kinase in neuromuscular and muscular disease. Pediatrics 35:322–330
Verellen C, Freund M, DeMeyer R, Laterre C, Scholberg B, Frédéric J (1977) Progressive muscular dystrophy of the Duchenne type in a young girl associated with an aberration of chromosome X. Excerpta Medica Int Congr Ser 426, p 42
Verril HL, Pickard NA, Gruemer HD (1977) Diminished cap formation in lymphocytes from patients and carriers of Duchenne muscular dystrophy. Clin Chem 23:2341–2343
Vickers JD, McComas AJ, Rathbone MP (1978) Alterations of membrane phosphorylation in erythrocyte membranes from patients with Duchenne muscular dystrophy. Can J Neurol Sci 5:437–442
Vignos PJ, Farah M, Evans E (1978) Affection cardiaque dans la dystrophie musculaire de Duchenne. Une étude échocardiographique préliminaire et clinique. Cahiers Rééd Réadapt 13:277–283
Vogel F (1955) Vergleichende Betrachtungen über die Mutationsrate der geschlechtsgebunden-rezessiven Hämophilieformen in der Schweiz und Dänemark. Blut 1:91–109
Vogel F (1956) Über die Prüfung von Modellvorstellungen zur spontanen Mutabilität an menschlichem Material. Z Menschl Vererb Konstitutionsl 33:470–491
Vogel F (1958) Gedanken über den Mechanismus einiger spontanen Mutationen beim Menschen. Z Menschl Vererb Konstitutionsl 34:389–399
Vogel F (1965) Sind die Mutationsraten für die X-chromosomal recessiven Haemophilieformen in Keimzellen von Frauen niedriger als in Keimzellen von Männern? Humangenetik 1:253–263
Vogel F (1977) A probable sex difference in some mutation rates. Am J Hum Genet 29:312–319
Vogel F, Rathenberg R (1975) Spontaneous mutations in man. In: Harris H, Hirschhorn K (eds) Advances in human genetics, vol 5. Plenum Press, New York London
Vogel F, Motulsky AG (1979) Human genetics. Problems and approaches. Springer, Berlin Heidelberg New York
Wacholtz MC, Raible DG, Jackowski S, Rodan SB, Rodan GA, Sha'afi RI (1979) Adenylate cyclase and ATPase activities in red cell membranes of patients and genetic carriers of Duchenne muscular dystrophy. Clin Chim Acta 96:255–259
Walton JN (1955) On the inheritance of muscular dystrophy. Ann Hum Genet 20:1–38
Walton JN (1957) The inheritance of muscular dystrophy. Acta Genet Stat Med 7:318–320
Walton JN, Gardner-Medwin D (1981) Progressive muscular dystrophy and the myotonic disorders. In: Walton JN (ed) Disorders of voluntary muscle, 4th ed. Churchill Livingstone, Edinburgh London Melbourne New York, pp 481–524
Wassner SJ, Li JB, Ladda RL, Lorenz RP, Emery AEH (1982) Prenatal diagnosis of Duchenne muscular dystrophy: Failure of amniotic fluid and maternal serum NT-methylhistidine analyses to detect affected fetuses. Am J Obstet Gynecol 143:216–219
Wertz RL, Roses AD (1982) Letter to the editor: premature aging of fibroblasts from patients with Duchenne muscular dystrophy. Pediatr Res 16:589–590
Wieacker P, Davies K, Pearson P, Ropers HH (1983) Carrier detection in Duchenne muscular dystrophy by use of cloned DNA sequences. Lancet i:1325–1326
Wilkerson LS, Perkins RC, Roelofs R, Swift L, Dalton LR, Park JH (1978) Erythrocyte membrane abnormalities in Duchenne muscular dystrophy monitored by saturation transfer electron paramagetic resonance spectroscopy. Proc Natl Acad Sci USA 75:838–841
Wilson KM, Evans KA, Carter CO (1965) Creatine kinase levels in women who carry genes for three types of muscular dystrophy. Br Med J 1:750–753
Williams WR, Thompson MW, Morton NE (1983) Complex segregation analysis and computer-assisted genetic risk assessment for Duchenne muscular dystrophy. Am J Med Genet 14:315–333
Winter RM (1980) Estimation of male to female ratio of mutation rates from carrier-detection tests in X-linked disorders. Am J Hum Genet 32:582–588
Winter RM, Pembrey ME (1982) Does unequal crossing over contribute to the mutation rate in Duchenne muscular dystrophy? Am J Med Genet 12:437–441
Wood DS, Sorenson M, Eastwood AB, Charash WE, Reuben JP (1978) Duchenne dystrophy: abnormal generation of tension and Ca++ regulation in single skinned fibers. Neurology 28:447–457
Worden DK, Vignos PJ Jr (1962) Intllectual function in childhood progressive muscular dystrophy. Pediatrics 29:968–977
Wrogeman K, Pena SDJ (1976) Mitochondrial calcium overload: a general mechanism for cell-necrosis in muscle diseases. Lancet i:672–673
Wyatt PR, Cox DM (1977) Duchenne's muscular dystrophy: Studies in cultured fibroblasts. Lancet i:172–174
Yasmineh WG, Ibrahim GA, Abbasnezhad M, Awad EA (1978) Isoenzyme distribution of creatine kinase and lactate dehydrogenase in serum and skeletal muscle in Duchenne muscular dystrophy, collagen disease, and other muscular disorders. Clin Chem 24:1985–1988
Yasuda N, Kondo K (1980) No sex difference in mutation rates of Duchenne muscular dystrophy. J Med Genet 17:106–111
Yasuda N, Kondo K (1982) The effect of parental age on rate of mutation for Duchenne muscular dystrophy. Am J Med Genet 13:91–99
Yoshioka M, Okuda R (1977) Human skeletal muscle fibers in normal and pathological states. Freeze-etch replica observations. J Electron Microsc 26:103–110
Yoshioka M (1981) Clinically manifesting carriers in Duchenne muscular dystrophy. Clin Genet 20:6–12
Zatz M, Otto PA (1980) Effect of age on the detection rate in Duchenne muscular dystrophy. J Neurol Sci 47:407–410
Zatz M (1983) Effect of genetic counseling on Duchenne muscular dystrophy families in Brazil. Am J Med Genet 15:483–490
Zatz M, Frota-Pessoa O, Peres CA (1975) Use of normal daughters' CPK levels in the estimation of heterozygosity risks in X-linked muscular dystrophies. Hum Hered 25:354–359
Zatz M, Frota-Pessoa A, Levy JA, Peres CA (1976) Creatine phosphokinase (CPK) activity in relatives of patients with X-linked muscular dystrophies: A Brazilian study. J Génét Hum 24:153–168
Zatz M, Shapiro LJ, Campion DS, Kaback MM, Otto PA (1980) Serum pyruvatekinase (PK) and creatine-phosphokinase (CPK) in female relatives and patients with X-linked muscular dystrophies (Duchenne and Becker). J Neurol Sci 46:267–279
Zatz M, Vianna-Morgante AM, Campos P, Diament AJ (1981) Translocation (X;6) in a female with Duchenne muscular dystrophy: implications for the localization of the DMD locus. J Med Genet 18:442–447
Zatz M, Karp LE, Rogatka A (1982) Pyruvate-kinase (PK) and creatine-kinase (CK) in normal pregnancy and its implication in genetic counseling of Duchenne muscular dystrophy (DMD). Am J Med Genet 13:257–262
Zatz M, Passos MR, Bortolini ER (1983) Letter to the editor: Serum pyruvate-kinase (PK) activity during pregnancy in potential carriers for Duchenne muscular dystrophy. Am J Med Genet 15:149–151
Zellweger H, Niedermeyer E (1965) Central nervous system manifestations in childhood muscular dystrophy. I. Psychometric and electroencephalographic findings. Ann Paediatr 205:25–42
Zellweger H, Hanson JW (1968) Psychometric studies in muscular dystrophy type IIIa (Duchenne). Dev Med Child Neurol 9:576–581
Zellweger H, Antonik A (1975) Newborn screening for Duchenne muscular dystrophys. Pediatrics 55:30–34
Author information
Authors and Affiliations
Additional information
This work was dedicated to Professor P.E. Becker in honour of his 75th birthday
Rights and permissions
About this article
Cite this article
Moser, H. Duchenne muscular dystrophy: Pathogenetic aspects and genetic prevention. Hum Genet 66, 17–40 (1984). https://doi.org/10.1007/BF00275183
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00275183